Decrease of serum cholinesterase in colorectal cancer

被引：6
|
作者：
Morera Ocon, Francisco J.
Orts, Francisco Ripoll
Ximenez, Mario Garcia-Granero
Pastor, Maria Jose
Bernal Sprekelsen, Juan Carlos
机构：
[1] Hosp Gen Requena, Serv Cirurg Gen, E-46340 Valencia, Spain
[2] Hosp Gen Requena, Serv Anal Clin, Valencia, Spain
来源：
MEDICINA CLINICA | 2007年 / 129卷 / 19期
关键词：
cholinesterase activity; colorectal cancer; colon; surgery;
D O I：
10.1157/13113287
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BACKGROUND AND OBJECTIVE: Cholinesterase is an enzyme with an unknown physiologic function. Some situations are related to a decreased serum cholinesterase activity but those situations are not well defined and the responsible mechanisms are unknown. Malignancy is one of these situations. The aim of the study was to compare the cholinesterase activity between patients with and without colorectal cancer. PATIENTS AND METHOD: Case-control study of patients with colorectal cancer who underwent surgery in our hospital from March 05 to January 07. RESULTS: Patients from the cancer group had a significant decreased serum cholinesterase activity. CONCLUSIONS: Investigation of cholinesterase function in humans may result in new research lines in oncology treatment.
引用
收藏
页码：729 / 730
页数：2
相关论文
共 50 条
  • [31] Serum ferritin - Screening test for colorectal cancer?
    Scholefield, JH
    Robinson, MHE
    Bostock, K
    Brown, NS
    DISEASES OF THE COLON & RECTUM, 1998, 41 (08) : 1029 - 1032
  • [32] Serum zinc concentration in patients with colorectal cancer
    Zowczak-Drabarczyk, M
    Torlinska, T
    Iskra, M
    Mielcarz, G
    Matylla, G
    Torlinski, L
    TRACE ELEMENTS AND ELECTROLYTES, 2004, 21 (04) : 236 - 239
  • [33] Serum YKL-40 and colorectal cancer
    Cintin, C
    Johansen, JS
    Christensen, IJ
    Price, PA
    Sorensen, S
    Nielsen, HJ
    BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) : 1494 - 1499
  • [34] Serum irisin levels in colorectal cancer patients
    Celik, Z.
    Baygutalp, N. K.
    Kilic, A. F.
    Tekin, S. B.
    Bakan, E.
    Gul, M. A.
    Yuce, N.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (04) : 2474 - 2479
  • [35] Serum YKL-40 and colorectal cancer
    C Cintin
    J S Johansen
    I J Christensen
    P A Price
    S Sørensen
    H J Nielsen
    British Journal of Cancer, 1999, 79 : 1494 - 1499
  • [36] Global serum metabolomics profiling of colorectal cancer
    Hashim, Nurul Azmir Amir
    Ab-Rahim, Sharaniza
    Suddin, Leny Suzana
    Saman, Mohd Shahril Ahmad
    Mazlan, Musalmah
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 11 (01) : 3 - 14
  • [37] Cytokeratin Serum Biomarkers in Patients with Colorectal Cancer
    Holdenrieder, S.
    Stieber, P.
    Liska, V.
    Treska, V.
    Topolcan, O.
    Dreslerova, J.
    Matejka, V. M.
    Finek, J.
    Holubec, L.
    ANTICANCER RESEARCH, 2012, 32 (05) : 1971 - 1976
  • [38] Management of colorectal cancer and diabetes
    Yao, Caroline
    Nash, Guy F.
    Hickish, Tamas
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2014, 107 (03) : 103 - 109
  • [39] Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer
    Lu, Hailing
    Goodell, Vivian
    Disis, Mary L.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (02) : 235 - 244
  • [40] Serum Inflammatory Markers and Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases
    Ananthakrishnan, Ashwin N.
    Cheng, Su-Chun
    Cai, Tianxi
    Cagan, Andrew
    Gainer, Vivian S.
    Szolovits, Peter
    Shaw, Stanley Y.
    Churchill, Susanne
    Karlson, Elizabeth W.
    Murphy, Shawn N.
    Kohane, Isaac
    Liao, Katherine P.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (08) : 1342 - +
12345